These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 14767501

  • 1. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome.
    Brachet C, Azzi N, Demulder A, Devalck C, Gourdin A, Gulbis B, Klein A, Le PQ, Loop M, Sariban E, Ferster A.
    Bone Marrow Transplant; 2004 Apr; 33(8):799-803. PubMed ID: 14767501
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow transplantation or hydroxyurea for sickle cell anemia: long-term effects on semen variables and hormone profiles.
    Lukusa AK, Vermylen C, Vanabelle B, Curaba M, Brichard B, Chantrain C, Dupont S, Ferrant A, Wyns C.
    Pediatr Hematol Oncol; 2009 Jun; 26(4):186-94. PubMed ID: 19437321
    [Abstract] [Full Text] [Related]

  • 3. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium.
    Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A, Zenebergh A, Maes P, Dhooge C, Benoit Y, Beguin Y, Dresse MF, Sariban E.
    Bone Marrow Transplant; 1998 Jul; 22(1):1-6. PubMed ID: 9678788
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 9. Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study.
    Tavakkoli F, Nahavandi M, Wyche MQ, Castro O.
    Clin Ther; 2005 Jul; 27(7):1083-8. PubMed ID: 16154487
    [Abstract] [Full Text] [Related]

  • 10. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation.
    Seidel MG, Fritsch G, Matthes-Martin S, Lawitschka A, Lion T, Pötschger U, Rosenmayr A, Fischer G, Gadner H, Peters C.
    Haematologica; 2005 Oct; 90(10):1405-14. PubMed ID: 16219578
    [Abstract] [Full Text] [Related]

  • 12. Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience.
    Majumdar S, Robertson Z, Robinson A, Starnes S, Iyer R, Megason G.
    Bone Marrow Transplant; 2010 May; 45(5):895-900. PubMed ID: 19784079
    [Abstract] [Full Text] [Related]

  • 13. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
    Iyamu EW, Cecil R, Parkin L, Woods G, Ohene-Frempong K, Asakura T.
    Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
    [Abstract] [Full Text] [Related]

  • 14. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 15. Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists.
    Zumberg MS, Reddy S, Boyette RL, Schwartz RJ, Konrad TR, Lottenberg R.
    Am J Hematol; 2005 Jun; 79(2):107-13. PubMed ID: 15929107
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimen.
    Tolar J, Bonfim C, Grewal S, Orchard P.
    Bone Marrow Transplant; 2006 Dec; 38(12):783-7. PubMed ID: 17086207
    [Abstract] [Full Text] [Related]

  • 18. Stem-cell transplantation in children and adults with sickle cell disease: an update.
    Khoury R, Abboud MR.
    Expert Rev Hematol; 2011 Jun; 4(3):343-51. PubMed ID: 21668398
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Results and current indications of bone marrow allograft in sickle cell disease].
    Bernaudin F.
    Pathol Biol (Paris); 1999 Jan; 47(1):59-64. PubMed ID: 10081781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.